193 related articles for article (PubMed ID: 9621071)
1. Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene.
Reuss FU; Coffin JM
J Virol; 1998 Jul; 72(7):6073-82. PubMed ID: 9621071
[TBL] [Abstract][Full Text] [Related]
2. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment.
Tovar Sepúlveda VA; Berdel B; Coffin JM; Reuss FU
Virology; 2000 Sep; 275(1):98-106. PubMed ID: 11017791
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of mouse mammary tumor virus superantigen expression by an intragenic enhancer.
Reuss FU; Coffin JM
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9293-7. PubMed ID: 7568120
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
Xu L; Wrona TJ; Dudley JP
Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
[TBL] [Abstract][Full Text] [Related]
5. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.
Wang Y; Jiang JD; Xu D; Li Y; Qu C; Holland JF; Pogo BG
Cancer Res; 2004 Jun; 64(12):4105-11. PubMed ID: 15205319
[TBL] [Abstract][Full Text] [Related]
6. The mouse mammary tumor virus transcription enhancers for hematopoietic progenitor and mammary gland cells share functional elements.
Reuss FU; Coffin JM
J Virol; 2000 Sep; 74(17):8183-7. PubMed ID: 10933730
[TBL] [Abstract][Full Text] [Related]
7. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
Wrona TJ; Lozano M; Binhazim AA; Dudley JP
J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
[TBL] [Abstract][Full Text] [Related]
8. Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat.
Yanagawa S; Murakami A; Tanaka H
J Virol; 1990 Jun; 64(6):2474-83. PubMed ID: 2159524
[TBL] [Abstract][Full Text] [Related]
9. Rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in T-cell leukemias of mouse strain GR result in a novel enhancer-like structure.
Michalides R; Wagenaar E; Weijers P
Mol Cell Biol; 1985 Apr; 5(4):823-30. PubMed ID: 2985971
[TBL] [Abstract][Full Text] [Related]
10. Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignancies.
Etkind PR; Stewart AF; Dorai T; Purcell DJ; Wiernik PH
Clin Cancer Res; 2004 Sep; 10(17):5656-64. PubMed ID: 15355890
[TBL] [Abstract][Full Text] [Related]
11. Detection of MMTV-like LTR and LTR-env gene sequences in human breast cancer.
Wang Y; Pelisson I; Melana SM; Holland JF; Pogo BG
Int J Oncol; 2001 May; 18(5):1041-4. PubMed ID: 11295054
[TBL] [Abstract][Full Text] [Related]
12. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat.
Günzburg WH; Heinemann F; Wintersperger S; Miethke T; Wagner H; Erfle V; Salmons B
Nature; 1993 Jul; 364(6433):154-8. PubMed ID: 8391646
[TBL] [Abstract][Full Text] [Related]
13. Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region.
Zhang DJ; Tsiagbe VK; Huang C; Thorbecke GJ
J Immunol; 1996 Oct; 157(8):3510-7. PubMed ID: 8871650
[TBL] [Abstract][Full Text] [Related]
14. Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat.
Hsu CL; Fabritius C; Dudley J
J Virol; 1988 Dec; 62(12):4644-52. PubMed ID: 2846876
[TBL] [Abstract][Full Text] [Related]
15. C3H mouse mammary tumor virus superantigen function requires a splice donor site in the envelope gene.
Mustafa F; Lozano M; Dudley JP
J Virol; 2000 Oct; 74(20):9431-40. PubMed ID: 11000212
[TBL] [Abstract][Full Text] [Related]
16. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
Barnett A; Mustafa F; Wrona TJ; Lozano M; Dudley JP
J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761
[TBL] [Abstract][Full Text] [Related]
17. Superantigen expression is driven by both mouse mammary tumor virus long terminal repeat-associated promoters in transgenic mice.
Salmons B; Miethke T; Wintersperger S; Müller M; Brem G; Günzburg WH
J Virol; 2000 Mar; 74(6):2900-2. PubMed ID: 10684308
[TBL] [Abstract][Full Text] [Related]
18. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
[TBL] [Abstract][Full Text] [Related]
19. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
Xu L; Wrona TJ; Dudley JP
Virology; 1996 Jan; 215(2):113-23. PubMed ID: 8560758
[TBL] [Abstract][Full Text] [Related]
20. Mouse mammary tumor proviral gene expression in cells of the B lineage.
Corley RB; Lund FE; Randall TD; King LB; Doerre S; Woodland DL
Semin Immunol; 1992 Oct; 4(5):287-96. PubMed ID: 1336679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
